Urology Times video interviews will feature expert discussion on prostate, kidney, and bladder cancer research from the Genitourinary Cancers Symposium in San Francisco.
Urology Times video interviews will feature expert discussion on prostate, kidney, and bladder cancer research from the Genitourinary Cancers Symposium in San Francisco.
UGN-102 reaches nearly 80% complete response rate in low-grade intermediate-risk NMIBC
November 30th 2023Primary chemoablative therapy with the mitomycin-containing reverse thermal gel UGN-102 induced complete responses in nearly 4 out of 5 patients with low-grade intermediate-risk non–muscle-invasive bladder cancer.